Financings in Brief: EndoSonics/CardioVascular Dynamics
This article was originally published in The Gray Sheet
Executive Summary
EndoSonics/CardioVascular Dynamics: EndoSonics, owner of 33% of former subsidiary CVD, plans to distribute to EndoSonics shareholders Sept. 26 one share of CVD for every 25 shares of EndoSonics held as of Sept. 5. Rancho Cordova, California-based EndoSonics will distribute about 770,000 shares of CVD all together -- which will reduce its stake to about 25%, or 2.2 mil. shares...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.